Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001619856-24-000064
Filing Date
2024-08-06
Accepted
2024-08-06 16:08:32
Documents
87
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crbu-20240630.htm   iXBRL 10-Q 1171313
2 EX-10.1 crbu-20240630xexx101x2024x.htm EX-10.1 8086
3 EX-31.1 crbu-20240630xexx311.htm EX-31.1 10315
4 EX-31.2 crbu-20240630xexx312.htm EX-31.2 10319
5 EX-32.1 crbu-20240630xexx321.htm EX-32.1 4687
6 EX-32.2 crbu-20240630xexx322.htm EX-32.2 4676
  Complete submission text file 0001619856-24-000064.txt   7189737

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20240630.xsd EX-101.SCH 51523
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crbu-20240630_cal.xml EX-101.CAL 70428
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crbu-20240630_def.xml EX-101.DEF 234327
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20240630_lab.xml EX-101.LAB 599340
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20240630_pre.xml EX-101.PRE 442091
89 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20240630_htm.xml XML 1096415
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40631 | Film No.: 241179238
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)